50 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Nemaura Medical Inc. NMRD shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors.
• Chiasma, Inc. CHMA gained 53.5% to $4.36 after Amryt Pharma agreed to acquire the company in an all-stock combination.
• iBio, Inc. IBIO jumped 47.3% to $1.90 after the company announced it successfully resolved its lawsuit with Fraunhofer USA.
• Athenex, Inc. ATNX shares climbed 43% to $5.30 after the company reported its acquired Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront.
• Regional Health Properties, Inc. RHE gained 40.4% to $13.94.
• Hayward Holdings, Inc. HAYW jumped 23.6% to $23.97 after the company reported better-than-expected Q1 sales.
• Superior Industries International, Inc. SUP gained 20.6% to $6.19 following Q1 results.
• Big 5 Sporting Goods Corporation BGFV surged 20% to $22.89 after the company reported better-than-expected Q1 results and also issued strong Q2 EPS guidance.
• Ault Global Holdings, Inc. DPW gained 17.3% to $3.11 after the company reported it sees preliminary Q1 sales of $13 million, up 132% year over year.
• DAVIDsTEA Inc. DTEA shares jumped 16.5% to $3.75 after the company announced it will seek court authorization for Companies' Creditors Arrangement Act.
• Rocky Brands, Inc. RCKY surged 15.7% to $62.35 after reporting a rise in quarterly earnings.
• KAR Auction Services, Inc. KAR shares rose 15.7% to $16.79 following upbeat quarterly results.
• Caesarstone Ltd. CSTE gained 15% to $16.59 following strong quarterly results.
• Medifast, Inc. MED gained 15% to $258.70 after the company reported better-than-expected Q1 results and issued strong FY21 EPS and sales guidance.
• Clovis Oncology, Inc. CLVS jumped 14.2% to $6.29 after the company posted a narrower-than-expected quarterly loss.
• Oceaneering International, Inc. OII gained 13.8% to $13.40. B of A Securities upgraded Oceaneering International from Neutral to Buy and raised the price target from $12.5 to $15.
• American Shared Hospital Services AMS rose 13.2% to $3.08 after dropping over 27% on Tuesday.
• Navios Maritime Holdings Inc. NM gained 13.2% to $10.27.
• XP Inc. XP climbed 13.1% to $43.47 after the company reported Q1 net income and total gross sales results up from last year.
• MRC Global Inc. MRC surged 12.5% to $10.86.
• Fresh Del Monte Produce Inc. FDP gained 12.3% to $32.44 following strong quarterly earnings.
• Belden Inc. BDC surged 10.7% to $47.71 after the company reported better-than-expected Q1 results and raised FY21 sales guidance.
• Nabors Industries Ltd. NBR gained 9.3% to $88.62.
• NOW Inc. DNOW gained 8.8% to $11.08 after the company reported better-than-expected Q1 results.
• Caesars Entertainment, Inc. CZR rose 6.5% to $101.77 after the company reported Q1 earnings results.
• Alteryx, Inc. AYX shares rose 6.3% to $81.17 after the company reported better-than-expected Q1 results.
• Match Group, Inc. MTCH rose 5% to $145.12 after the company reported better-than-expected Q1 sales and issued strong Q2 sales guidance.
• Activision Blizzard, Inc. ATVI rose 4.2% to $92.36 after the company reported Q1 earnings results and issued Q2 guidance.

Check out these big penny stock gainers and losers

Losers

• Cocrystal Pharma, Inc. COCP shares fell 32.2% to $1.45 after the company announced a $40 million bought deal offering of common stock.
• Intrusion Inc. INTZ fell 28.6% to $10.28 after the company reported worse-than-expected Q1 results. B. Riley FBR downgraded Intrusion from Buy to Neutral and lowered the price target from $30 to $13.5.
• Esperion Therapeutics, Inc. ESPR shares dropped 26.7% to $18.77 after the company reported worse-than-expected Q1 results. Stifel downgraded Esperion Therapeutics from Buy to Hold and lowered the price target from $37 to $20.
• Mercury Systems, Inc. MRCY fell 19.8% to $56.28 after reporting Q3 results.
• Adamis Pharmaceuticals Corporation ADMP fell 19.4% to $0.8620 after surging 40% on Tuesday.
• Rayonier Advanced Materials Inc. RYAM dropped 19.1% to $7.37 after reporting a loss for its first quarter.
• Bottomline Technologies (de), Inc. EPAY dipped 16.6% to $38.62 after the company reported worse-than-expected Q3 sales results. Craig-Hallum downgraded Bottomline Technologies from Buy to Hold.
• Precipio, Inc. PRPO shares fell 16% to $4.41. Recently, the company successfully launched its COVID-19 rapid antibody test that tests for both IgG & IgM antibodies.
• Astec Industries, Inc. ASTE dropped 16% to $64.46 following downbeat quarterly results.
• IM Cannabis Corp. IMCC fell 15.1% to $5.45 after the company reported pricing of proposed public offering of securities.
• Kimball International, Inc. KBAL dropped 14.4% to $12.47 following weak quarterly results.
• Lumber Liquidators Holdings, Inc. LL fell 14.35% to $21.22 following downbeat quarterly sales.
• BioLineRx Ltd. BLRX fell 14% to $4.2006. BioLineRx shares climbed 53% on Tuesday after the company announced positive top-line results from the GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, in combination with granulocyte colony stimulating factor, the standard-of-care, for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.
• Systemax Inc. SYX dropped 14% to $36.71 after the company posted downbeat quarterly results.
• FedNat Holding Company FNHC fell 13.4% to $4.45 following weak quarterly results.
• Upwork Inc. UPWK dropped 12% to $37.78 after the company reported Q1 earnings results.
• Cardlytics, Inc. CDLX fell 10.3% to $115.02 after reporting a Q1 loss.
• SemiLEDs Corporation LEDS fell 10.3% to $5.33 after jumping 58% on Tuesday.
• CyberArk Software Ltd. CYBR dipped 9.5% to $122.15 after the company issued mixed Q2 guidance.
• Dolby Laboratories, Inc. DLB fell 9% to $94.22 after the company issued Q3 EPS guidance below analyst estimates. The company also said Lewis Chew, Executive Vice President and Chief Financial Officer has decided to retire later this year.
• HollyFrontier Corporation HFC fell 8.1% to $33.27 after the company reported a Q1 loss and announced the acquisition of Puget Sound Refinery for $350 million.
• Brooklyn ImmunoTherapeutics, Inc. BTX fell 6% to $51.96. Last week, Brooklyn ImmunoTherapeutics filed a Form 8-K showing that it entered into a purchase agreement with Lincoln Park Capital on Apr. 26 in which the company can sell up to $20 million of common shares to the Chicago-based investment group and asset management firm. Additionally, Nicholas J Singer disclosed that he took a 9%-plus stake in the company in a 13G filing on Friday.